Jump to content
RemedySpot.com

Refractory Central Nervous System Vasculitis and Gastrocnemius Myalgia Syndrome in Crohn's Disease Successfully Treated with Anti-Tumor Necrosis Factor-α Antibody

Rate this topic


Guest guest

Recommended Posts

Guest guest



doi:10.1016/j.semarthrit.2008.01.008 Copyright © 2008 Elsevier Inc. All rights reserved.

Brief Report

Refractory Central Nervous System Vasculitis and Gastrocnemius Myalgia Syndrome in Crohn's Disease Successfully Treated with Anti-Tumor Necrosis Factor-α Antibody

Sebastian Ullrich MD, , ne Schinke MD†, Markus Both MD‡, Karl Christian Knop MD§, Coula Kirkiles- MD¶, Wolfgang Ludwig Gross MD† and Lamprecht MD† †University of Lübeck, Department of Rheumatology, UKSH Vasculitis Center and Rheumaklinik Bad Bramstedt, Bramstedt, Germany‡Radiology Department, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, GermanyDepartment of Anathomy II, Center for Experimental Medicine, University Hospital of Hamburg, Hamburg, Germany§Department of Neurology, St. Georg Hospital, Hamburg, Germany¶Yale University, Department of Immunobiology, New Haven, CT Available online 4 March 2008.

Background

Secondary vasculitis represents a rare extraintestinal manifestation of Crohn's disease (CD). Appropriate and prompt diagnosis is often delayed by uncertainties about the relationship of the vasculitic manifestations and CD. Objective

To describe our experience with vasculitis in CD and review the literature with respect to different manifestations and pathophysiological aspects of extraintestinal vasculitic manifestations of CD. Methods

We report 2 new cases of CD with secondary small-vessel vasculitis. We also extensively review the literature (1960-2007) using a broad range of key words related to secondary vasculitis in CD. Relevant publications were evaluated for the number of reported patients and manifestations of vasculitis. Results

Vasculitis is a rare extraintestinal manifestation of CD. Different types of vasculitis affect large-, medium-, and small-sized vessels associated with CD. Common immunologic features include intestinal inflammation as well as an infiltration of γδ-T-cells and/or Th1-type cells into vessel walls. The 2 new cases of secondary vasculitis in CD reported here reflect 2 major types of CD-related inflammatory vascular disorders. The first involves the central nervous system, while the second represents circumscribed Musculus gastrocnemius involvement (so-called “gastrocnemius myalgia syndromeâ€). Successful treatment of refractory secondary vasculitis in CD with an anti-tumor necrosis factor-α antibody is shown for the first time. Conclusion

Vasculitis secondary to CD is an uncommon finding. Therefore, it has to be carefully differentiated from other forms of primary or secondary vasculitis with intestinal involvement. Treatment with an anti- tumor necrosis factor-α antibody may prove a treatment option in vasculitis as an extraintestinal manifestation of CD.

Keywords: vasculitis; Crohn's disease; anti-TNF alpha; Takayasu's syndrome; gastrocnemius; myalgia; syndrome; CNS-vasculitis; T-lymphocyte Abbreviations: ANCA, antineutrophil cytoplasmatic antibodies; CD, Crohn's disease; CDAI, Crohn's disease activity index; CNS, central nervous system; CRP, C-reactive protein; CSF, cerebrospinal fluid; MRI, magnetic resonance imaging; MTX, methotrexate; TNF-α, tumor necrosis factor

Address reprint requests to:

Note to users: The section "Articles in Press" contains peer reviewed accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated published journal issue. The date it was first made available online will be carried over. Please be aware that although "Articles in Press" do not have all bibliographic details available yet, they can already be cited using the year of online publication and the DOI as follows: Author(s), Article Title, Journal (Year), DOI. Please consult the journal's reference style for the exact appearance of these elements, abbreviation of journal names and the use of punctuation.

There are three types of "Articles in Press":

Accepted manuscripts: these are articles that have been peer reviewed and accepted for publication by the Editorial Board. The articles have not yet been copy edited and/or formatted in the journal house style. Uncorrected proofs: these are copy edited and formatted articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Corrected proofs: these are articles containing the authors' corrections and may, or may not yet have specific issue and page numbers assigned.

Seminars in Arthritis and Rheumatism Article in Press, Corrected Proof

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...